Anika Therapeutics Inc - ESG Rating & Company Profile powered by AI
The Sustainability score for Anika Therapeutics Inc represents its reporting of the United Nations Sustainable Development Goals. If you are employed by Anika Therapeutics Inc and you wish to licence your ESG aseessment, please contact us. Detailed Sustainability assessment of Anika Therapeutics Inc can be reached by registering for free.
Anika Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.0, social score of 4.8 and governance score of 3.2.
3.3
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1234 | Quanterix Corp | 3.4 | Medium |
1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
1253 | Anika Therapeutics Inc | 3.3 | Medium |
1253 | Calithera Biosciences Inc | 3.3 | Medium |
1253 | Cara Therapeutics Inc | 3.3 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Anika Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Does Anika Therapeutics Inc disclose current and historical energy intensity?
Does Anika Therapeutics Inc report the average age of the workforce?
Does Anika Therapeutics Inc reference operational or capital allocation in relation to climate change?
Does Anika Therapeutics Inc disclose its ethnicity pay gap?
Does Anika Therapeutics Inc disclose cybersecurity risks?
Does Anika Therapeutics Inc offer flexible work?
Does Anika Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Anika Therapeutics Inc disclose the number of employees in R&D functions?
Does Anika Therapeutics Inc conduct supply chain audits?
Does Anika Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Anika Therapeutics Inc conduct 360 degree staff reviews?
Does Anika Therapeutics Inc disclose the individual responsible for D&I?
Does Anika Therapeutics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Anika Therapeutics Inc disclose current and / or historical scope 2 emissions?
Does Anika Therapeutics Inc disclose water use targets?
Does Anika Therapeutics Inc have careers partnerships with academic institutions?
Did Anika Therapeutics Inc have a product recall in the last two years?
Does Anika Therapeutics Inc disclose incidents of discrimination?
Does Anika Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Has Anika Therapeutics Inc issued a profit warning in the past 24 months?
Does Anika Therapeutics Inc disclose parental leave metrics?
Does Anika Therapeutics Inc disclose climate scenario or pathway analysis?
Does Anika Therapeutics Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Anika Therapeutics Inc disclose the pay ratio of women to men?
Does Anika Therapeutics Inc support suppliers with sustainability related research and development?
Does Anika Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Anika Therapeutics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Anika Therapeutics Inc involved in embryonic stem cell research?
Does Anika Therapeutics Inc disclose GHG and Air Emissions intensity?
Does Anika Therapeutics Inc disclose its waste policy?
Does Anika Therapeutics Inc report according to TCFD requirements?
Does Anika Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Anika Therapeutics Inc disclose energy use targets?
Does Anika Therapeutics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Anika Therapeutics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Anika Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.